FGF2 and bone neoplasm: Taking these results into consideration, we assume that APT-F2P might be effective in ameliorating chronic pain associated with FGF2 overproduction, such as in bone cancer, but not acute pain unassociated with FGF2 overproduction, such as in immediate postoperation.